Cannabis firm raises stg£25m

GW Pharmaceuticals, which is developing the world's first cannabis-based medicine for pain relief, has raised stg£25m through an initial public offering.

Cannabis firm raises stg£25m

GW Pharmaceuticals, which is developing the world's first cannabis-based medicine for pain relief, has raised stg£25m through an initial public offering.

Chief executive Geoffrey Guy will see his paper fortune valued at stg£47m when the company floats on the junior AIM stock market next Thursday.

Already a subscriber? Sign in

You have reached your article limit.

Unlimited access. Half the price.

Annual €120 €60

Best value

Monthly €10€5 / month

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited